Clinical Trial Update: Epothilone B in Treating Patients With CNS Metastases From Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Epothilone B in patients with CNS metastases from breast cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Epothilone B (epothilone B)

Snippet

Sponsor: David Peereboom, MD | Conditions: Breast Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-10-09